A B C D E F G H I J K L M N O P Q R S T U V W X Y Z #

Muscular Dystrophy Advanced Evaluation

Test Code
901618


CPT Codes
81161, 81404 (x4), 81405 (x9), 81406 (x7), 81408 (x2), 81479<br><strong>CPT coding may differ dependent on payer rules which may impact prior authorization testing.</strong><br><strong>Please direct any questions regarding CPT coding to the payer being billed.</strong><br><br><strong>&#8288;&#8288;&#8288;&#8288;&#8288;&#8288;&#8288;Limited Access Code</strong>

Preferred Specimen
8 mL whole blood collected in two EDTA (lavender-top) tubes
Pediatric (0-3 Years): 2 mL


Minimum Volume
6 mL • Pediatric: 1 mL


Instructions
Overnight shipping preferred


Transport Temperature
Room temperature


Specimen Stability
Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable


Methodology
Next Generation Sequencing

FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule
Set up: Varies; Report available: 21-28 days


Reference Range
See Laboratory Report


Clinical Significance
Tests for sequence variations in 33 genes, including duplications/deletions in 4 of these genes that are associated with muscle weakness and wasting of variable and heterogeneous severity, age of onset, rate of progression, mode of inheritance, and complications.




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.